LipiSperse® Bioavailability Dispersion

Power Up Dispersion

Advanced Dispersion Technology

Scientifically proven, multi-award winning LipiSperse® is an advanced cold water dispersion technology (CWD). Allowing solid/powder lipophilic active ingredients such as curcumin, resveratrol, palmitoylethanolamide (PEA) and quercetin with otherwise relatively low bioavailability and poor solubility in water, to be easily dispersed in cold water, thereby increasing their bioavailability and uptake in the body.

LipiSperse®’s superior performance means only 10% LipiSperse® is required with an impressive 90% active load, the largest active/nutrient ratio in a water dispersible formulation.

LipiSperse® advantages

  • higher active loads

  • optimised bioavailability

  • improved functionality

  • higher efficacy

  • clinically validated

  • water dispersible

  • multi award winning

  • Australian developed and made

  • patented technology

LipiSperse repulsive forces

HydroCurc® + reduces inflammatory responses post Covid-19 infection

The published study highlights the positive impact of HydroCurc® supplementation on the immune response in post COVID-19 and subsequently vaccinated adults.

HydroCurc®+ decreasing joint pain and improving quality of life

This 2 week study demonstrated that a single dose of HydroCurc®, the bioavailable curcumin is an effective option for rapidly reducing joint pain.

HydroCurc® + FS iron, Reduces inflammation markers

The 3rd study by University of Westminster study on HydroCurc® co-supplemented with Ferrous Sulphate, has shown a reduction in oxidative stress and systemic-inflammation.

HydroCurc® + FS iron has not impairment on iron absorption

The 2nd study conducted by University of Westminster has demonstrated that supplementation of HydroCurc® with Ferrous Sulphate, does not negatively influence acute iron absorption in healthy adults.

Levagen®+ Palmitoyl-ethanolamide for reduced sleep disturbance

This study aimed to asses the impact on sleep measures when administered Levagen®+ at a 350mg dose. The findings support Levagen®+ as a potential sleeping aid capable of reducing sleep onset time and improving cognition on waking.

Veri-Sperse® Trans -resveratrol optimised with LipiSperse® increases bioavailability

This study showed that a single dose of trans-resveratrol with LipiSperse® resulted in a 1.6-fold increase in resveratrol-sulfate conjugate, and a 2-fold increase in glucuronide conjugate.

HydroCurc® Improves Delayed Onset Muscle Soreness and Postexercise Lactate Accumulation

The efficacy of curcumin supplementation is traditionally limited due to its poor bioavailability, however HydroCurc® curcumin has been shown to improve biomarkers of muscle damage post exercise.

HydroCurc® taken with FS iron increases BDNF serum levels

A large study conducted at Westminster University has shown that supplementing HydroCurc® with iron significantly increases serum BDNF (Brain-Derived Neurotrophic Factor) levels which cross the blood brain barrier, essential for neuronal health.

Levagen®+ increases bioavailability of PEA formulating with LipiSperse® technology

LipiSperse® dispersion technology as Levagen®+ has been used in a pharmacokinetic study to evaluate the absorption of Palmitoylethanolamide (PEA-Levagen®).

Levagen®+ aids in muscle recovery

The study aimed to compare the bioavailability of a single dose of commercially available PEA with LipiSperse® (the delivery complex) in an Exercise Study, demonstrating Levagen®+ aids in muscle recovery.

Levagen®+ a treatment for reducing pain and other symptoms of knee osteoarthritis

The study was to assess the safety, tolerability and efficacy of palmitoylethanolamide (PEA) when dosed at 300 mg and 600 mg per day on symptoms of knee osteoarthritis.

HydroCurc® increases bioavailability of curcumin with LipiSperse®

The aim of this study was to investigate the pharmacokinetics of HydroCurc® (a commercially available curcumin extract), with or without the curcumin-LipiSperse® delivery complex.

Awards and Grants

Ingredient of the Year Healthy Ageing HydroCurc®

USA and EU

Ingredient of the Year Sports Nutrition HydroCurc®

Ingredient of the Year Sports Nutrition HydroCurc®

Research Project of the Year Levagen®+

USA
Ingredient of the Year Healthy Ageing Levagen®+

EU

Editors Award for Innovation

Asia

Research Project of the Year LipiSperse®

Ingredient of the Year Cognitive Function HydroCurc®

Botanical Product of the Year HydroCurc®

2020

Best Sports Nutrition Product HydroCurc®

2019

Most Innovative Idea LipiSperse®

The Commonwealth Department of Industry, Innovations Connection Grant for HydroCurc® study (National Institute of Complementary Medicine/University of Western Sydney)

LipiSperse® is a patented technology, and a trademark owned exclusively by Pharmako Biotechnologies Pty. Ltd., registered in Australia and other countries.